DYN
Dyne Therapeutics, Inc.
21.79
2 x 16.07
2 x 28.08
bid
ask
-
0.42
1.89%
2 @ 04:00 PM
22.00 +0.21 (0.96%)
| Ytd | 11.40% | |
| 1y | 151.04% |
21.70
day range
22.44
8.06
52 week range
25.00
| Open | 22.15 | Prev Close | 22.21 | Low | 21.70 | High | 22.44 | Mkt Cap | 3.60B |
| Vol | 1.33M | Avg Vol | 1.78M | EPS | -3.15 | P/E | N/A | Forward P/E | -7.28 |
| Beta | 1.08 | Short Ratio | 14.55 | Inst. Own | 115.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-27 | 50-d Avg | 18.51 | 200-d Avg | 17.97 | 1yr Est | 38.25 |
| Income Statement | |||
| Operating Expenses | 125.28M | ||
| Research and Development Expense | 100.89M | ||
| Selling, General and Administrative Expense | 24.39M | ||
| Operating Income | -125.28M | ||
| Interest Expense | 4.20M | ||
| Net Income | -120.85M | ||
| Net Income Common Stock | -120.85M | ||
| Net Income Common Stock (USD) | -120.85M | ||
| Consolidated Income | -120.85M | ||
| Earnings per Basic Share | -0.73 | ||
| Earnings per Basic Share (USD) | -0.73 | ||
| Earnings per Diluted Share | -0.73 | ||
| Earning Before Interest & Taxes (EBIT) | -116.65M | ||
| Earning Before Interest & Taxes (USD) | -116.65M | ||
| Weighted Average Shares | 165.04M | ||
| Weighted Average Shares Diluted | 165.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 753.10M | ||
| Cash and Equivalents (USD) | 753.10M | ||
| Investments | 219.05M | ||
| Investments Current | 219.05M | ||
| Current Assets | 1.02B | ||
| Property, Plant & Equipment Net | 43.33M | ||
| Total Assets | 1.08B | ||
| Debt Current | 11.26M | ||
| Total Debt | 174.90M | ||
| Current Liabilities | 51.25M | ||
| Debt Non-Current | 163.65M | ||
| Total Liabilities | 214.90M | ||
| Accumulated Retained Earnings (Deficit) | -1.52B | ||
| Accumulated Other Comprehensive Income | -137.00K | ||
| Shareholders Equity | 865.06M | ||
| Shareholders Equity (USD) | 865.06M | ||
| Assets Non-Current | 58.92M | ||
| Total Debt (USD) | 174.90M | ||
| Liabilities Non-Current | 163.65M | ||
| Trade and Non-Trade Payables | 10.78M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 666.00K | ||
| Net Cash Flow from Financing | 7.06M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -140.25M | ||
| Capital Expenditure | -221.00K | ||
| Issuance (Purchase) of Equity Shares | 887.00K | ||
| Issuance (Repayment) of Debt Securities | 6.18M | ||
| Net Cash Flow from Investing | -2.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.17M | ||
| Net Cash Flow from Operations | -144.92M | ||
| Share Based Compensation | 13.08M | ||